Chinese capital accesses Western innovation to create homegrown industry

February 9, 2017 Christoph Graener

With the Chinese market growing at 10–15% a year, it is poised to be world’s largest by 2026. Tony Chu, co-founder and managing partner at consultants TPP Healthcare, explains to Mike Ward, global director of content at Informa Pharma Intelligence’s insights portfolio, how Chinese capital is accessing Western innovation to build a PRC pharma industry.

Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Tony Chu – Founding Partner, TPP Healthcare

Previous Article
VIDEO: Innovation in an uncertain world
VIDEO: Innovation in an uncertain world

How are cutting-edge biotech companies trying to compete in a global marketplace dealing with drug-price an...

Next Article
Rare diseases, rare commitment
Rare diseases, rare commitment

Patients, their families and patient foundations are invaluable in helping drug developers understand the d...